Go Pro
TSE:CRON

Cronos Group Q1 2026 Earnings Report

Cronos Group logo
C$4.46 -0.01 (-0.22%)
As of 09/3/2026 04:00 PM Eastern

Cronos Group EPS Results

Actual EPS
C$0.06
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Cronos Group Revenue Results

Actual Revenue
$62.86 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Cronos Group Announcement Details

Quarter
Q1 2026
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Cronos Group Earnings Headlines

Cronos: Q2 Earnings Snapshot
The cat is out the bag
Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered separation packages to 8,500 workers, and Oracle is reportedly eliminating up to 30,000 positions. Goldman Sachs estimates 12,400 Americans are being financially displaced every single day. Analyst Porter Stansberry says the real driver runs deeper than AI - and two Nobel Prize winners have issued the same warning. He calls it the Final Displacement, and he's releasing a full investigation with specific companies to buy and sell before the next wave hits.tc pixel
See More Cronos Group Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cronos Group? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cronos Group and other key companies, straight to your email.

About Cronos Group

Cronos Group (TSE:CRON), headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.

View Cronos Group Profile